272 related articles for article (PubMed ID: 36969373)
1. Prime editing in hematopoietic stem cells-From
Wolff JH; Mikkelsen JG
Front Genome Ed; 2023; 5():1148650. PubMed ID: 36969373
[TBL] [Abstract][Full Text] [Related]
2. Base and Prime Editing Technologies for Blood Disorders.
Antoniou P; Miccio A; Brusson M
Front Genome Ed; 2021; 3():618406. PubMed ID: 34713251
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations.
Psatha N; Paschoudi K; Papadopoulou A; Yannaki E
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553489
[TBL] [Abstract][Full Text] [Related]
4. The p53 challenge of hematopoietic stem cell gene editing.
Dorset SR; Bak RO
Mol Ther Methods Clin Dev; 2023 Sep; 30():83-89. PubMed ID: 37435043
[No Abstract] [Full Text] [Related]
5. Prime Editing: An Emerging Tool in Cancer Treatment.
Sen D; Sarkar S; Mukhopadhyay P
Mol Biotechnol; 2023 Apr; 65(4):509-520. PubMed ID: 36251123
[TBL] [Abstract][Full Text] [Related]
6. Prime Editing in Plants: Prospects and Challenges.
Vats S; Kumar J; Sonah H; Zhang F; Deshmukh R
J Exp Bot; 2024 Feb; ():. PubMed ID: 38366636
[TBL] [Abstract][Full Text] [Related]
7. Generation of AAVS1 integrated doxycycline-inducible CRISPR-Prime Editor human induced pluripotent stem cell line.
Bharucha N; Ataam JA; Gavidia AA; Karakikes I
Stem Cell Res; 2021 Dec; 57():102610. PubMed ID: 34875545
[TBL] [Abstract][Full Text] [Related]
8. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.
Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615
[TBL] [Abstract][Full Text] [Related]
9. Improvement of base editors and prime editors advances precision genome engineering in plants.
Hua K; Han P; Zhu JK
Plant Physiol; 2022 Mar; 188(4):1795-1810. PubMed ID: 34962995
[TBL] [Abstract][Full Text] [Related]
10. Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells.
Salisbury-Ruf CT; Larochelle A
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535527
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas systems usher in a new era of disease treatment and diagnosis.
Li R; Wang Q; She K; Lu F; Yang Y
Mol Biomed; 2022 Oct; 3(1):31. PubMed ID: 36239875
[TBL] [Abstract][Full Text] [Related]
12. Search-and-replace genome editing without double-strand breaks or donor DNA.
Anzalone AV; Randolph PB; Davis JR; Sousa AA; Koblan LW; Levy JM; Chen PJ; Wilson C; Newby GA; Raguram A; Liu DR
Nature; 2019 Dec; 576(7785):149-157. PubMed ID: 31634902
[TBL] [Abstract][Full Text] [Related]
13. Introduction of mutations in plants with prime editing.
Hao L; Pu X; Song J
Methods; 2021 Oct; 194():83-93. PubMed ID: 33774158
[TBL] [Abstract][Full Text] [Related]
14. Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.
Iancu O; Allen D; Knop O; Zehavi Y; Breier D; Arbiv A; Lev A; Lee YN; Beider K; Nagler A; Somech R; Hendel A
Mol Ther Nucleic Acids; 2023 Mar; 31():105-121. PubMed ID: 36618262
[TBL] [Abstract][Full Text] [Related]
15. A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System.
Porteus MH; Pavel-Dinu M; Pai SY
Hematol Oncol Clin North Am; 2022 Aug; 36(4):647-665. PubMed ID: 35773054
[TBL] [Abstract][Full Text] [Related]
16. A straightforward plant prime editing system enabled highly efficient precise editing of rice Waxy gene.
Li Z; Ma R; Liu D; Wang M; Zhu T; Deng Y
Plant Sci; 2022 Oct; 323():111400. PubMed ID: 35905895
[TBL] [Abstract][Full Text] [Related]
17. An improved medium formulation for efficient
Rai R; Naseem A; Vetharoy W; Steinberg Z; Thrasher AJ; Santilli G; Cavazza A
Mol Ther Methods Clin Dev; 2023 Jun; 29():58-69. PubMed ID: 36950452
[TBL] [Abstract][Full Text] [Related]
18. Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates.
Romero Z; Lomova A; Said S; Miggelbrink A; Kuo CY; Campo-Fernandez B; Hoban MD; Masiuk KE; Clark DN; Long J; Sanchez JM; Velez M; Miyahira E; Zhang R; Brown D; Wang X; Kurmangaliyev YZ; Hollis RP; Kohn DB
Mol Ther; 2019 Aug; 27(8):1389-1406. PubMed ID: 31178391
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders.
Ugalde L; Fañanas S; Torres R; Quintana-Bustamante O; Río P
Cytotherapy; 2023 Mar; 25(3):277-285. PubMed ID: 36610813
[TBL] [Abstract][Full Text] [Related]
20. CRISPR medicine for blood disorders: Progress and challenges in delivery.
Mohammadian Gol T; Ureña-Bailén G; Hou Y; Sinn R; Antony JS; Handgretinger R; Mezger M
Front Genome Ed; 2022; 4():1037290. PubMed ID: 36687779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
